Shanghai YaKe Biotechnology Co., Ltd.
PrivateLast Round
Series A
May 1, 2016
Total Funding Raised
$1.53M
Company Overview
Shanghai YaKe Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in May 2016.
Shanghai YaKe Biotechnology Co., Ltd. is a biotechnology company that develops cancer immunotherapy technologies, specifically focusing on CAR-T cell therapies for B-cell malignancies and other blood cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai YaKe Biotechnology Co., Ltd. Comparables
Compare Shanghai YaKe Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PersonGen BioTherapeutics | 89% | |
| Shanghai Unicar-Therapy Bio-medicine Technology | 88% | |
| Shenzhen Pregene Bio-Pharmaceutical Co., Ltd. | 87% |
For institutional investors. Book with your work email.
Shanghai YaKe Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Shanghai YaKe Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai YaKe Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai YaKe Biotechnology Co., Ltd. a public or private company?
Shanghai YaKe Biotechnology Co., Ltd. is a private company.
What is the current stock price of Shanghai YaKe Biotechnology Co., Ltd.?
Shanghai YaKe Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai YaKe Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai YaKe Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Shanghai YaKe Biotechnology Co., Ltd. is not publicly available.
Can I buy Shanghai YaKe Biotechnology Co., Ltd. stock?
Shanghai YaKe Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai YaKe Biotechnology Co., Ltd.'s last funding round?
Shanghai YaKe Biotechnology Co., Ltd.'s most recent funding round was Series A on May 1, 2016.
Who are the main investors in Shanghai YaKe Biotechnology Co., Ltd.?
Investor information for Shanghai YaKe Biotechnology Co., Ltd. is not publicly disclosed.
Will Shanghai YaKe Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai YaKe Biotechnology Co., Ltd..
How can I track Shanghai YaKe Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai YaKe Biotechnology Co., Ltd.'s shares on secondary markets.